UNSPSC 51332514: Trifluperidol

This classification denotes an antipsychotic agent with the molecular formula C22H23F4NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8869Q7R8I, chemically known as 4-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)butyrophenone but generally known as trifluperidol, which bears US NIH Compound Identifier 5567. European Medicines Agency schedules Trifluperidol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11289MIG.

UNSPSC 51332514 Trifluperidol (Commodity) covers pharmaceutical products that state and local governments procure to support public health and emergency response initiatives. The recent activity under this code reflects state and local acquisition of naloxone and drug deactivation systems for community health programs, though the UNSPSC category name does not fully capture the breadth of pharmaceutical goods being sourced. Issuing bodies under this code include county health departments and community health agencies responsible for opioid response and harm reduction services.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement carries a two-year initial term with one-year renewal option, fixed-fee pricing, and a three-month probationary period. Vendors must comply with drug-free workplace and E-Verify requirements, maintain specified insurance coverages including workers' compensation and commercial general liability, and absorb all shipping and delivery costs in their bid pricing. The contract is potentially funded through FEMA, introducing additional federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Bids were due July 26, 2023, at 2:00 pm, with questions due by July 21, 2023.